Pedro E Cahn

9PUBLICATIONS
58CO-AUTHORS
Pharmaceutical delivery technologiesGene and molecular therapyTransgender studiesSensory processes, perception and performancePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 30, 2026
Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study.

|Jul 29, 2026
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.

|Jul 20, 2026
Sociodemographic and Behavioral Characteristics and HIV and Syphilis Prevalence Among Partners of Transgender Women in Buenos Aires, Argentina.

|Apr 17, 2026
Viral variant but not host factors associate with SARS-CoV-2 viral kinetics.

|Sep 02, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Antidrug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.

Peter A Leone, Alejandro Ferro, Charlotte-Paige Rolle

|Aug 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Maria Ines Figueroa, Carlos Brites, Diego Cecchini

Pageof 2

Frequent Collaborators

2 joint publications

Charlotte-Paige Rolle

1 joint publications

Ezequiel Lacunza

1 joint publications

Romina Canzoneri

1 joint publications

Julián Naipauer